vs

Side-by-side financial comparison of AbbVie (ABBV) and Mastercard (MA). Click either name above to swap in a different company.

AbbVie is the larger business by last-quarter revenue ($15.0B vs $8.8B, roughly 1.7× Mastercard). Mastercard runs the higher net margin — 46.1% vs 4.6%, a 41.5% gap on every dollar of revenue. On growth, Mastercard posted the faster year-over-year revenue change (17.6% vs 9.9%). Over the past eight quarters, Mastercard's revenue compounded faster (17.8% CAGR vs 1.8%).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

Mastercard Inc. is an American multinational payment card services corporation headquartered in Purchase, New York. It offers a range of payment transaction processing and other related-payment services. Throughout the world, its principal business is to process payments between the banks of merchants and the card-issuing banks or credit unions of the purchasers who use the Mastercard-brand debit, credit and prepaid cards to make purchases. Mastercard has been publicly traded since 2006.

ABBV vs MA — Head-to-Head

Bigger by revenue
ABBV
ABBV
1.7× larger
ABBV
$15.0B
$8.8B
MA
Growing faster (revenue YoY)
MA
MA
+7.7% gap
MA
17.6%
9.9%
ABBV
Higher net margin
MA
MA
41.5% more per $
MA
46.1%
4.6%
ABBV
Faster 2-yr revenue CAGR
MA
MA
Annualised
MA
17.8%
1.8%
ABBV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ABBV
ABBV
MA
MA
Revenue
$15.0B
$8.8B
Net Profit
$697.0M
$4.1B
Gross Margin
Operating Margin
26.6%
55.8%
Net Margin
4.6%
46.1%
Revenue YoY
9.9%
17.6%
Net Profit YoY
-45.9%
21.5%
EPS (diluted)
$0.39
$4.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABBV
ABBV
MA
MA
Q1 26
$15.0B
Q4 25
$16.6B
$8.8B
Q3 25
$15.8B
$8.6B
Q2 25
$15.4B
$8.1B
Q1 25
$13.3B
$7.3B
Q4 24
$15.1B
$7.5B
Q3 24
$14.5B
$7.4B
Q2 24
$14.5B
$7.0B
Net Profit
ABBV
ABBV
MA
MA
Q1 26
$697.0M
Q4 25
$1.8B
$4.1B
Q3 25
$186.0M
$3.9B
Q2 25
$938.0M
$3.7B
Q1 25
$1.3B
$3.3B
Q4 24
$-22.0M
$3.3B
Q3 24
$1.6B
$3.3B
Q2 24
$1.4B
$3.3B
Gross Margin
ABBV
ABBV
MA
MA
Q1 26
Q4 25
72.6%
Q3 25
66.4%
Q2 25
71.8%
Q1 25
70.0%
Q4 24
70.9%
Q3 24
70.9%
Q2 24
70.9%
Operating Margin
ABBV
ABBV
MA
MA
Q1 26
26.6%
Q4 25
27.3%
55.8%
Q3 25
12.1%
58.8%
Q2 25
31.7%
58.7%
Q1 25
28.0%
57.2%
Q4 24
-9.9%
52.6%
Q3 24
26.5%
54.3%
Q2 24
27.6%
58.0%
Net Margin
ABBV
ABBV
MA
MA
Q1 26
4.6%
Q4 25
10.9%
46.1%
Q3 25
1.2%
45.7%
Q2 25
6.1%
45.5%
Q1 25
9.6%
45.2%
Q4 24
-0.1%
44.6%
Q3 24
10.8%
44.3%
Q2 24
9.5%
46.8%
EPS (diluted)
ABBV
ABBV
MA
MA
Q1 26
$0.39
Q4 25
$1.02
$4.52
Q3 25
$0.10
$4.34
Q2 25
$0.52
$4.07
Q1 25
$0.72
$3.59
Q4 24
$-0.03
$3.64
Q3 24
$0.88
$3.53
Q2 24
$0.77
$3.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABBV
ABBV
MA
MA
Cash + ST InvestmentsLiquidity on hand
$10.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$7.7B
Total Assets
$54.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABBV
ABBV
MA
MA
Q1 26
Q4 25
$5.3B
$10.6B
Q3 25
$5.7B
$10.3B
Q2 25
$6.5B
$9.0B
Q1 25
$5.2B
$7.6B
Q4 24
$5.6B
$8.4B
Q3 24
$7.3B
$11.1B
Q2 24
$13.2B
$7.0B
Total Debt
ABBV
ABBV
MA
MA
Q1 26
Q4 25
$58.9B
Q3 25
$63.0B
Q2 25
$63.0B
Q1 25
$64.5B
Q4 24
$60.3B
Q3 24
$58.5B
Q2 24
$58.0B
Stockholders' Equity
ABBV
ABBV
MA
MA
Q1 26
Q4 25
$-3.3B
$7.7B
Q3 25
$-2.6B
$7.9B
Q2 25
$-183.0M
$7.9B
Q1 25
$1.4B
$6.7B
Q4 24
$3.3B
$6.5B
Q3 24
$6.0B
$7.4B
Q2 24
$6.8B
$7.4B
Total Assets
ABBV
ABBV
MA
MA
Q1 26
Q4 25
$134.0B
$54.2B
Q3 25
$133.9B
$53.3B
Q2 25
$137.2B
$51.4B
Q1 25
$136.2B
$48.5B
Q4 24
$135.2B
$48.1B
Q3 24
$143.4B
$47.2B
Q2 24
$141.9B
$42.3B
Debt / Equity
ABBV
ABBV
MA
MA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
45.44×
Q4 24
18.15×
Q3 24
9.70×
Q2 24
8.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABBV
ABBV
MA
MA
Operating Cash FlowLast quarter
$5.0B
Free Cash FlowOCF − Capex
$4.9B
FCF MarginFCF / Revenue
55.5%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
1.23×
TTM Free Cash FlowTrailing 4 quarters
$17.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABBV
ABBV
MA
MA
Q1 26
Q4 25
$5.2B
$5.0B
Q3 25
$7.0B
$5.7B
Q2 25
$5.2B
$4.6B
Q1 25
$1.6B
$2.4B
Q4 24
$7.0B
$4.8B
Q3 24
$5.4B
$5.1B
Q2 24
$2.3B
$3.1B
Free Cash Flow
ABBV
ABBV
MA
MA
Q1 26
Q4 25
$4.9B
$4.9B
Q3 25
$6.6B
$5.5B
Q2 25
$4.9B
$4.6B
Q1 25
$1.4B
$2.2B
Q4 24
$6.8B
$4.7B
Q3 24
$5.2B
$5.0B
Q2 24
$2.0B
$3.0B
FCF Margin
ABBV
ABBV
MA
MA
Q1 26
Q4 25
29.4%
55.5%
Q3 25
42.1%
63.8%
Q2 25
31.7%
56.1%
Q1 25
10.5%
30.6%
Q4 24
44.7%
63.3%
Q3 24
35.9%
68.2%
Q2 24
14.0%
43.4%
Capex Intensity
ABBV
ABBV
MA
MA
Q1 26
Q4 25
2.0%
1.3%
Q3 25
2.4%
2.1%
Q2 25
1.7%
0.5%
Q1 25
1.8%
2.2%
Q4 24
1.9%
1.3%
Q3 24
1.7%
1.5%
Q2 24
1.7%
1.7%
Cash Conversion
ABBV
ABBV
MA
MA
Q1 26
Q4 25
2.87×
1.23×
Q3 25
37.76×
1.44×
Q2 25
5.49×
1.24×
Q1 25
1.27×
0.73×
Q4 24
1.45×
Q3 24
3.49×
1.57×
Q2 24
1.66×
0.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABBV
ABBV

Segment breakdown not available.

MA
MA

Payment Network$4.9B56%
Value Added Services And Solutions$3.9B44%

Related Comparisons